Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 238-245

  Sidhu, Jaspreet S ^a   Omiecinski, Curtis J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,9 DIDEOXYFORSKOLIN; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 7BETA DEACETYL 7BETA (1 METHYL 4 PIPERAZINYL)FORSKOLIN; ADENYLATE CYCLASE; BUCLADESINE; COMPLEMENTARY DNA; CYCLIC AMP; CYTOCHROME P450; DEXAMETHASONE; FORSKOLIN; GLUCAGON; ISOBUTYLMETHYLXANTHINE; L 858051; MESSENGER RNA; PHENOBARBITAL; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FORSKOLIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTRACELLULAR FLUID; KINETICS; LIVER; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PHOSPHODIESTERASE INHIBITORS; RATS; RNA, MESSENGER; STIMULATION, CHEMICAL;

EID: 0029998716     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. BIRD, I. M., MASON, J. I., OKA, K. AND RAINEY, W. E.: Angiotensin-II stimulates an increase in cAMP and expression of 17α-hydroxylase cytochrome P450 in fetal bovine adrenocortical cells. Endocrinology 132: 932-934, 1993
2. BOUTILLIER, A -L , BARTHEL, F., ROBERTS, J. L. AND LOEFFLER, J.-P.: β-Adrenergic stimulation of c-fos via protein kinase A is mediated by cAMP regulatory element binding protein (CREB)-dependent and tissue-specific CREB-independent mechanisms in corticotropic cells. J. Biol. Chem. 267: 23520-23526, 1991.
3. 2+ current in cardiac cells. Mol. Pharmacol. 38: 758-765, 1990.
4. BURGER, H.-J., SCHUETZ, J. D., SCHUETZ, E. G. AND GUZELIAN, P. S.: Paradoxical transcriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16α-carbonitrile: Analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 89: 2145-2149, 1992.
5. CAO, L., ZLOCK, D W. AND GARDNER, D. G.: Differential regulation of natriuretic peptide receptor activity in vascular cells. Hypertension 24: 329-338, 1994.
6. CHENG, C. Y. AND HORNSBY, P. J.: Expression of 11β-hydroxylase and 21-hydroxylase in long-term cultures of bovine adrenocortical cells requires extracellular matrix factors. Endocrinology 130: 2883-2889, 1992.
7. CHOMCZYNSKI, P. AND SACCHI, N.: Single-step method of mRNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
8. DUBEY, M. P., SRIMAL, R. C., NITYANANO, S. AND DHAWAN, B. N.: Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii. J. Ethopharmacol. 3: 1-13, 1981.
9. GONZALEZ, F. J.: Molecular genetics of the P-450 superfamily. Pharmacol. Ther. 45: 1-38, 1990.
10. GONZALEZ, F. J., SONG, B.-J. AND HARDWICK, J. P.: Pregnenolone 16α-carbonitrile-inducible P-450 gene family: Gene conversion and differential regulation. Mol. Cell. Biol. 6: 2969-2976, 1986.
11. HARTZELL, H. C. AND BUDNITZ, D.: Differences in effects of forskolin and an analog on calcium currents in cardiac myocytes suggest intra- and extracellular sites of action. Mol. Pharmacol. 41: 880-888, 1992.
12. HASSETT, C., TURNBOLM, S. M., DEANGELES, A. AND OMIECINSKI, C. J.: Rabbit microsomal epoxide hydrolase: Isolation and characterization of the xenobiotic metabolizing enyme cDNA. Arch. Biochem. Biophys. 271: 380-389, 1989.
13. + channels is independent of adenylate cyclase activation Science (Wash. DC) 240: 1652-1655, 1988.
14. HUANG, R. D., SMITH, M. F AND ZAHLER, W. L.: Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents. J. Cyclic Nucleotide Res. 8: 385-394, 1982.
15. JEHAN, F., NEVEU, I., NAVEILHAN, P., BRACHET, P. AND WION, D.: Complex interactions among second messenger pathways, steroid hormones, and protooncogenes of the fos and jun families converge in the regulation of the nerve growth factor gene. J. Neurochem. 60: 1843-1853, 1993.
16. JOOST, H G., HABBERFIELD, A. D., SIMPSON, I. A., KAURENZA, A. AND SEAMON, K. B.: Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: Structural determinants for distinct sites of action. Mol. Pharmacol. 33: 449-453, 1988.
17. JOOST, H. G. AND STEINFELDER, H. J.: Forskolin inhibits insulin-stimulated glucose transport in rat adipose cells by a direct interaction with the glucose transporter. Mol. Pharmacol. 31: 279-283, 1987.
18. KAI, H , GRIENDLING, K. K., LASSEGUE, B., OLLERENSHAW, J. D., RUNGE, M S. AND ALEXANDER, R. W.: Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 24: 523-527, 1994.
19. KOCAREK, T. A., SCHUETZ, E. G. AND GUZELIAN, P. S.: Differential induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of adult rat hepatocytes. Mol. Pharmacol. 38: 440-444, 1990.
20. LAURENZA, A., KHANDELWAL, Y., DESOUZA, N. J., RUPP, R H., METZGER, H AND SEAMON, K. B.: Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Mol Pharmacol. 32: 133-139, 1987.
21. LAURENZA, A , ROBBINS, J. D. AND SEAMON, K. B.: Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: Synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase. Mol. Pharmacol. 41: 360-368, 1992.
22. LAURENZA, A., SUTKOWSKI, E. M. AND SEAMON, K. B : Forskolin: A specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol. Sci. 10: 442-447, 1989.
23. LINDNER, E., DOHADWALLA, A. N. AND BHATTACHARYA, B. K.: Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli. Arzneim.-Forsch. 28: 284-289, 1978.
24. LIPPINCOTT-SCHWARTZ, J., GLICKMAN, J., DONALDSON, J. G., ROBBINS, J., KREIS, T. E., SEAMON, K. B., SHEETZ, M. P. AND KLAUSNER, R. D.: Forskolin inhibits and reverses the effects of Brefeldin A on Golgi morphology by a cAMP-independent mechanism. J. Cell. Biol. 112: 567-577, 1991.
25. 3-24-hydroxylase by forskolin: Evidence for a 3′,5′-cyclic adenosine monophosphate-independent mechanism. Endocrinology 130: 2145-2151, 1992.
26. MAY, J. M. AND DANZO, B. J.: Photolabeling of the human erythrocyte glucose carrier wih androgenic steroids. Biochim. Biophys. Acta 943: 199-210, 1988.
27. METZGER, H. AND LINDNER, E : The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneim.-Forsch. 31: 1248-1250, 1981.
28. MEYER, T. E. AND HABENER, J F.: Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocr. Rev. 14: 269-290, 1993.
29. MORRIS, D. I., SPEICHER, L. A., RUOHO, A. E., TEW, K. D. AND SEAMON, K. B.: Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry 30: 8371-8379, 1991.
30. NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R , GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K. AND NEBERT, D. W. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell. Biol. 12: 1-51, 1993.
31. OKEY, A. B.: Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 45: 241-248, 1990.
32. OMIECINSKI, C. J., HASSETT, C. AND COSTA, P.: Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1. Mol. Pharmacol. 38: 462-470, 1990.
33. RIABOWOL, K. T., FINK, J. S., GILMAN, M. Z., WALSH, D. A., GOODMAN, R. H. AND FERAMISCO, J. R.: The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer element. Nature (Lond) 336: 83-86, 1988.
34. ROBBERECHT, P. M., WAELBROECK, M., CHATELAIN, P , CAMUS, J. C. AND CHRISTOPHE, J.: Inhibition of forskolin-stimulated cardiac adenylate cyclase activated by short chain alcohols. FEBS Lett. 154: 205-208, 1983.
35. ROBBINS, J. D., LAURENZA, A., KOSLEY, K. W , JR., O'MALLEY, G. J., SPAHL, B. AND SEAMON, K. B.: (Aminoalkyl)carbamates of forskolin: Intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter. J. Med. Chem. 34: 3204-3212, 1991.
36. SCHMID, E , SCHMID, W., JANTZEN, M., MAYER, D., JASTORFF, B. AND SCHUTZ, G.: Transcription activation of the tyrosiue aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes. Eur. J. Biochem 165: 499-506, 1987.
37. SCHUETZ, E. G. AND GUZELIAN, P S.: Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J. Biol. Chem. 259: 2007-2012, 1984.
38. SCHUETZ, E. G., WRIGHTON, S. A., BARWICK, J. L. AND GUZELIAN, P. S.: Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16 alpha-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver in vivo. J Biol. Chem. 259: 1999-2006, 1984.
39. SEAMON, K. B. AND DALY, J. W.: Forskolin: A unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7: 201-224, 1981.
40. SEAMON, K. B. AND DALY, J. W : Forskolin: Its biological and chemical properties. Adv. Cyclic Nucleotide Res. 20: 1-150, 1986
41. SEAMON, K. B., PADGETT, W. AND DALY, J. W.. Forskolin-unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. U.S A. 78: 3363-3367, 1981.
42. SEGLEN, P. O.: Preparation of isolated liver cells. Methods Biol. 13: 433-447, 1976.
43. SHALINSKY, D. R., HEATH, D. D., JEKUNEN, A. P., ALCARAZ, J. E. AND HOWELL, S. B : Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells. Br. J. Cancer 67: 471-479, 1993.
44. 3H forskolin. Direct photoaffinity labeling of the erythrocyte D-glucose transporter. J. Biol Chem. 262: 5978-5984, 1987.
45. SHEPPARD, H., WIGGAN, G. AND TSIEN, W. H.: Structure-activity relationaships for inhibitors of phosphodiesterase from erythrocytes and other tissues. Adv. Cyclic Nucleotide Res 1: 103-112, 1972.
46. SIDHU, J. S., FARIN, F. M., KAVANAGH, T. J. AND OMIECINSKI, C. J.: Effect of tissue-culture substratum and extracellular matrix (ECM) overlay on liver-selective and xenobiotic inducible gene expression in primary rat hepatocytes. In Vitro Toxicol. 7: 225-242, 1994.
47. SIDHU, J. S., FARLN, F. M. AND OMIECINSKI, C J.: Influence of extracellular matrix overlay on phenobarbital-mediated induction of P4502B1, 2B2 and 3A1 genes in primary rat hepatocyte culture. Arch. Biochem. Biophys. 301: 103-113, 1993.
48. SIDHU, J. S AND OMIECINSKI, C. J.: Modulation of xenobiotic-inducible cytochrome P450 gene expression by dexamethasone in primary rat hepatocytes. Pharmacogenetics 5: 24-36, 1995a.
49. SIDHU, J. S. AND OMIECINSKI, C. J.: cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures J. Biol. Chem. 70: 12672-12773, 1995b.
50. SPAULDING, S. W.: The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr. Rev. 14: 632-650, 1993.
51. STAECKER, J. L. AND PITOT, H. C.: The effect of sodium butyrate on tyrosine aminotransferase induction in primary cultures of normal adult rat hepatocytes. Arch. Bioehem. Biophys. 261: 291-298, 1988.
52. A receptor desensitization in chick cortical neurons. Synapse 4: 126-131, 1989
53. URBAN, R. J., GARMEY, J. C., SHUFNIK, M. A. AND VELDHUIS, J. D.. Follicle-stimulating hormone increases concentrations of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage enzyme in primary cultures of porcine granulosa cells. Endocrinology 128: 2000-2007, 1991.
54. WADLER, S. AND WIERNIK, P. H.: Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variants. Cancer Res. 48: 539-543, 1988.
55. WHITE, G., LI, C. AND ISHAC, E.: 1,9-Dideoxyforskolin does not mimic all cAMP and protein kinase A independent effects of forskolin on GABA activated ion currents in adult rat sensory neurons. Brain Res. 586: 157-161, 1992.
56. WRIGHT, M. C. AND PAINE, A. J.: Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein. Biochem. Biophys. Res. Commun. 201: 973-979, 1994.